Literature DB >> 3080779

Platelet 3H-imipramine binding and steroid hormones serum concentrations during the menstrual cycle.

M F Poirier, C Benkelfat, A M Galzin, S Z Langer.   

Abstract

The presence of high affinity binding sites for 3H-imipramine (3H-IMI) in human platelets is by now well established. This recognition site is associated with the transporter for 5HT, and may be a biological marker in depression. Fluctuations of other putative biological markers of depression (i.e. platelet MAO activity) have been demonstrated and shown to be correlated with variations in steroid hormones. Therefore, the KD and Bmax of 3H-IMI binding was determined in platelets of young women during the menstrual cycle. Our results indicate that within the limits of intraindividual variations, neither the KD or the Bmax of 3H-IMI binding in platelets is significantly modified during the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080779     DOI: 10.1007/bf00310518

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Maturational changes in blood serotonin levels and platelet counts.

Authors:  E Ritvo; A Yuwiler; E Geller; S Plotkin; A Mason; K Saeger
Journal:  Biochem Med       Date:  1971-02

2.  Evidence that the spleen retains the youngest and hemostatically most effective platelets.

Authors:  N R Shulman; S P Watkins; S B Itscoitz; A B Students
Journal:  Trans Assoc Am Physicians       Date:  1968

3.  The development of a menstrual distress questionnaire.

Authors:  R H Moos
Journal:  Psychosom Med       Date:  1968 Nov-Dec       Impact factor: 4.312

4.  High affinity 3H-imipramine binding in human platelets: age and sex effects.

Authors:  M Baron; S Kowalik; A Barkai; R Gruen
Journal:  Neuropsychobiology       Date:  1984       Impact factor: 2.328

5.  Platelet count during normal pregnancy.

Authors:  K L Harrison; L Bramich; K A Collins
Journal:  Aust N Z J Obstet Gynaecol       Date:  1982-05       Impact factor: 2.100

6.  Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume.

Authors:  S Karpatkin
Journal:  Blood       Date:  1978-02       Impact factor: 22.113

7.  High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders.

Authors:  S Z Langer; E Zarifian; M Briley; R Raisman; D Sechter
Journal:  Life Sci       Date:  1981-07-20       Impact factor: 5.037

8.  Does high affinity [3H] imipramine binding label serotonin reuptake sites in brain and platelet?

Authors:  S M Paul; M Rehavi; K C Rice; Y Ittah; P Skolnick
Journal:  Life Sci       Date:  1981-06-15       Impact factor: 5.037

9.  Demographic, biologic, and other variables affecting monoamine oxidase activity.

Authors:  D S Robinson; A Nies
Journal:  Schizophr Bull       Date:  1980       Impact factor: 9.306

10.  3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers.

Authors:  R Raisman; M S Briley; F Bouchami; D Sechter; E Zarifian; S Z Langer
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more
  4 in total

1.  Lack of effect of oestradiol implant on platelet imipramine and 5-HT2 receptor binding in menopausal subjects.

Authors:  N R Best; D H Barlow; M P Rees; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  Platelet research in psychiatry.

Authors:  A Wirz-Justice
Journal:  Experientia       Date:  1988-02-15

3.  Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle.

Authors:  Susan E Best; Philip M Sarrel; Robert T Malison; Marc Laruelle; Sami S Zoghbi; Ronald M Baldwin; John P Seibyl; Robert B Innis; Christopher H van Dyck
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

4.  Chronic GnRH agonist administration down-regulates platelet serotonin transporter in women undergoing assisted reproductive treatment.

Authors:  S Eyal; A Weizman; P Toren; Y Dor; R Mester; M Rehavi
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.